Across five cancers, Medicaid beneficiaries were between 11% and 42% more likely than privately insured patients to wait more than a month for treatment. Medicare patients fared somewhat better but were still between 4% and 12% more likely to wait a month or more than individuals with private coverage.
Medicaid and Medicare patients are more likely than patients with private coverage to face extended emergency-room waits before being admitted to a hospital.
The low down on Roy Cohn. (The Atlantic)
No more GLP-1?
A handful of major corporations have recently said they are ending coverage of GLP-1s specifically for obesity, including PepsiCo, Starbucks, PwC, and HCA Healthcare. Large health insurers, state Medicaid plans, and public-sector employers have been cutting GLP-1 coverage for weight loss since 2024. (Statnews)